Course: Advances in Eyecare: Developments in maintaining ocular health, Section: Learning objectives

General

Ocular Examination Contact Lenses Options Knowledge

No CPD Points

In this edition of Advances in Eyecare we hear from three experts about developments in maintaining ocular health. The speakers discuss their fields of research as applicable to optometric practice.

Dr Nicole Carnt outlines the nature of Acanthamoeba keratitis, its causes, diagnosis, management and avoidance. There is some discussion of why there has been an increase in incidence in some UK areas in the last year.

Prof Niall Strang looks at the latest views on the use of low-dose atropine in the slowing of myopic progression and the likely potential this may have for the future for UK-based practitioners in myopia therapy.

Dr Tariq Aslam looks at the review of the Royal College of Ophthalmologists (RCO) guidelines for the screening for retinal disease due to the systemic use of chloroquine and hydroxychloroquine and how the optometrist may be usefully involved in the multidisciplinary approach to future screening and monitoring.

Last published: December 2019

Learning objectives

1.1.1 Understand the nature of Acanthamoeba keratitis, its diagnosis and management.

2.1.2 Understand the current recommendations for the screening of chloroquine and hydroxychloroquine toxicity.

2.5.3 Understand the evidence base relating to the use of atropine in myopia therapy and so be better able to advise patients on the outcomes so far indicated by published research.

3.1.3 Understand the latest imaging techniques available to detect maculopathic changes due to systemic drugs such as chloroquine before significant vision impact is established.

5.2.1 Understand the risk of Acanthamoeba keratitis with soft contact lens wear and how to best advise the patient to avoid it.

6.1.7 Understand the nature of Acanthamoeba keratitis, its diagnosis and management.

6.1.15 Understand the potential adverse ocular effects of systemic chloroquine and hydroxychloroquine use and how these may be best screened for under the latest RCO guidelines.